Skip to content

Clinical trials

Phase 2 Congenital Hyperinsulinism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Hyperinsulinism Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20092
20151
20162
20171
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Philadelphia2
Xeris Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
Filip Krag Knop1
Hanmi Pharmaceutical Company Limited1
Miguel Pampaloni1
Montefiore Medical Center1
Rezolute1
University Hospital, Gentofte, Copenhagen1
XOMA (US) LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Hyperinsulinism12
Hypoglycemia6
Hyperinsulinism4
Digestive System Diseases1
Glucose Metabolism Disorders1
Insulinoma1
Metabolic Diseases1
Pancreatic Diseases1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.